Observational studyClinical rheumatology2026

Long-term effectiveness and safety of annual biosimilar Rituximab retreatment in seropositive Rheumatoid Arthritis: A 4-year real-world study.

Syamasis Bandyopadhyay et al.PubMed ↗Publisher ↗

No numbers read from the abstract.